en
Scientific article
Open access
English

68Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia

Published inThe Journal of clinical endocrinology and metabolism, vol. 101, no. 10, p. 3575-3581
Publication date2016
Abstract

Phosphaturic mesenchymal tumors (PMTs) are small, typically difficult to localize, and express somatostatin receptors. Recent work suggests imaging studies using 68Gallium (68Ga)-conjugated somatostatin peptide analogues, such as 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)TATE, which enables somatostatin receptor imaging with positron emission tomography (PET), may be useful at identifying these tumors.

Citation (ISO format)
EL-MAOUCHE, Diala et al. 68Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia. In: The Journal of clinical endocrinology and metabolism, 2016, vol. 101, n° 10, p. 3575–3581. doi: 10.1210/jc.2016-2052
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0021-972X
456views
361downloads

Technical informations

Creation11/22/2016 9:20:00 AM
First validation11/22/2016 9:20:00 AM
Update time03/15/2023 1:08:55 AM
Status update03/15/2023 1:08:54 AM
Last indexation01/16/2024 10:42:41 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack